Literature DB >> 7522413

Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate.

D G Bostwick, F Algaba, M B Amin, A Ayala, J Eble, N Goldstein, B Helpap, P Humphrey, D Grignon, E C Jones.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 7522413

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


× No keyword cloud information.
  5 in total

Review 1.  The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update.

Authors:  B G Helpap; D G Bostwick; R Montironi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.

Authors:  Debra L Zynger; Ximing Yang
Journal:  Int J Clin Exp Pathol       Date:  2008-12-22

3.  Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma.

Authors:  Roberta Mazzucchelli; Marina Scarpelli; Francesca Barbisan; Alfredo Santinelli; Antonio Lopez-Beltran; Liang Cheng; Rodolfo Montironi
Journal:  Cell Oncol (Dordr)       Date:  2012-11-07       Impact factor: 6.730

4.  Prenatal and pubertal testosterone exposure imprint permanent modifications in the prostate that predispose to the development of lesions in old Mongolian gerbils.

Authors:  Manoel F Biancardi; Ana Ps Perez; Cássia Rs Caires; Luiz R Falleiros; Rejane M Góes; Patrícia Sl Vilamaior; Diógenes R Freitas; Fernanda Ca Santos; Sebastião R Taboga
Journal:  Asian J Androl       Date:  2017 Mar-Apr       Impact factor: 3.285

5.  Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer? A long-term retrospective study in Norway.

Authors:  S Harvei; F J Skjørten; T E Robsahm; A Berner; S Tretli
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.